402 related articles for article (PubMed ID: 30156519)
1. [Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life].
Devecioğlu E; Gökçay G; Boran P; Eren T; Yılmaz G; Badur S
Mikrobiyol Bul; 2018 Jul; 52(3):324-327. PubMed ID: 30156519
[TBL] [Abstract][Full Text] [Related]
2. Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants.
Malshe N; Palkar S; Kulkarni R; Lalwani S; Mishra AC; Arankalle V
Vaccine; 2019 Mar; 37(11):1443-1448. PubMed ID: 30765170
[TBL] [Abstract][Full Text] [Related]
3. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.
Waaijenborg S; Hahné SJ; Mollema L; Smits GP; Berbers GA; van der Klis FR; de Melker HE; Wallinga J
J Infect Dis; 2013 Jul; 208(1):10-6. PubMed ID: 23661802
[TBL] [Abstract][Full Text] [Related]
4. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of maternally transferred antibodies against measles, mumps, and rubella in infants in Sri Lanka.
Muthiah N; Galagoda G; Handunnetti S; Peiris S; Pathirana S
Int J Infect Dis; 2021 Jun; 107():129-134. PubMed ID: 33895406
[TBL] [Abstract][Full Text] [Related]
7. Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants.
van den Berg JP; Westerbeek EA; Smits GP; van der Klis FR; Berbers GA; van Elburg RM
PLoS One; 2014; 9(4):e94714. PubMed ID: 24728480
[TBL] [Abstract][Full Text] [Related]
8. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
Durando P; Esposito S; Bona G; Cuccia M; Desole MG; Ferrera G; Gabutti G; Pellegrino A; Salvini F; Henry O; Povey M; Marchetti F
Vaccine; 2016 Aug; 34(36):4278-84. PubMed ID: 27423382
[TBL] [Abstract][Full Text] [Related]
9. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.
Lalwani S; Chatterjee S; Balasubramanian S; Bavdekar A; Mehta S; Datta S; Povey M; Henry O
BMJ Open; 2015 Sep; 5(9):e007202. PubMed ID: 26362659
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
[TBL] [Abstract][Full Text] [Related]
12. Immunity of nursing students to measles, mumps, rubella, and varicella in Yozgat, Turkey.
Kader Ç; Erbay A; Akça NK; Polat MF; Polat S
Am J Infect Control; 2016 Jan; 44(1):e5-7. PubMed ID: 26442461
[TBL] [Abstract][Full Text] [Related]
13. Combination measles, mumps, rubella and varicella vaccine.
Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
[TBL] [Abstract][Full Text] [Related]
14. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
[TBL] [Abstract][Full Text] [Related]
15. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
[No Abstract] [Full Text] [Related]
16. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
Leung JH; Hirai HW; Tsoi KK
Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
20. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
Kanamori H; Tokuda K; Ikeda S; Endo S; Ishizawa C; Hirai Y; Takahashi M; Aoyagi T; Hatta M; Gu Y; Yano H; Weber DJ; Kaku M
Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
